Table: Brightpath Biotherapeutics - 9-MTH group results

BrightPath Biotherapeutics Co

14/02/2019 06:00

Feb 14 (Reuters)- 
             Brightpath Biotherapeutics Co., Ltd. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended        Year to  
                Dec 31, 2018        Dec 31, 2017      Mar 31, 2019  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales            154 mln             246 mln           150 mln    
                 (-37.3 pct)         (-42.8 pct)       (-57.7 pct)  
  Operating       loss 1.28           loss 1.17         loss 2.20   
  Recurring       loss 1.27           loss 1.17         loss 2.20   
  Net             loss 1.47           loss 1.18         loss 2.20   
  EPS          loss 35.09 yen      loss 31.52 yen    loss 52.59 yen 
  Ann Div                                NIL               NIL      
  -Q2 div            NIL                 NIL                        
  -Q4 div                                NIL               NIL      
  
  NOTE - Brightpath Biotherapeutics Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4594.T